Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer
will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.
- will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.
- He will add great depth to our management team, said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova.
- I am thrilled that Mark will be joining Onconova and eager to begin working together.
- Dr. Gelder is an accomplished industry leader with more than 35 years of experience in clinical development, medical affairs, and medical marketing.